Mesa Laboratories Inc (MLAB)
101.28
+1.16
(+1.16%)
USD |
NASDAQ |
Apr 19, 15:55
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 546.31M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -38.65% |
| Valuation | |
| PE Ratio | 595.76 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 2.562 |
| Price to Book Value | 1.356 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | 0.16 |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.5781 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 74.40% |
Profile
| Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in 4 divisions: Sterilization and Disinfection Control, which manufactures and sells biological, cleaning, and chemical indicators. It also provides testing and laboratory services, mainly to the dental industry; Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions; Calibration Solutions division develops, manufactures, and sells quality control and calibration products used to measure or calibrate temperature, pressure, pH, humidity, and other such parameters for health and safety purposes; and Clinical Genomics. Its geographical segments include United States and Foreign. |
| URL | https://www.mesalabs.com |
| Investor Relations URL | https://investors.mesalabs.com |
| HQ State/Province | Colorado |
| Sector | Health Care |
| Industry | Life Sciences Tools & Services |
| Equity Style | Small Cap/Blend |
| Next Earnings Release | May. 24, 2024 (est.) |
| Last Earnings Release | Feb. 05, 2024 |
| Next Ex-Dividend Date | May. 31, 2024 |
| Last Ex-Dividend Date | Feb. 28, 2024 |
Ratings
Profile
| Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in 4 divisions: Sterilization and Disinfection Control, which manufactures and sells biological, cleaning, and chemical indicators. It also provides testing and laboratory services, mainly to the dental industry; Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions; Calibration Solutions division develops, manufactures, and sells quality control and calibration products used to measure or calibrate temperature, pressure, pH, humidity, and other such parameters for health and safety purposes; and Clinical Genomics. Its geographical segments include United States and Foreign. |
| URL | https://www.mesalabs.com |
| Investor Relations URL | https://investors.mesalabs.com |
| HQ State/Province | Colorado |
| Sector | Health Care |
| Industry | Life Sciences Tools & Services |
| Equity Style | Small Cap/Blend |
| Next Earnings Release | May. 24, 2024 (est.) |
| Last Earnings Release | Feb. 05, 2024 |
| Next Ex-Dividend Date | May. 31, 2024 |
| Last Ex-Dividend Date | Feb. 28, 2024 |